Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 93 clinical trials
Featured trial
Personalizing Sleep Interventions to Prevent Type 2 Diabetes in Community Dwelling Adults With Pre-Diabetes

This study will use continuous glucose monitoring and actigraphy to examine whether a personalized, daily sleep extension intervention improves glucose regulation for community dwelling, sleep-restricted adults with pre-diabetes. The randomized controlled trial will include 150 adults with pre-diabetes. Sleep extension and habitual sleep groups will complete daily sleep diaries and …

  • 0 views
  • 19 Feb, 2024
Featured trial
Internet Intervention for Diabetes Distress.

This study is designed to investigate the potential effectiveness of an internet-delivered intervention for diabetes distress in patients with type 2 diabetes.

Accepts healthy volunteers
  • 0 views
  • 19 Feb, 2024
  • 19 locations
Featured trial
  • 0 views
  • 26 Apr, 2024
  • 5 locations
Featured trial
  • 0 views
  • 19 Sep, 2024
  • 1 location
Featured trial
  • 0 views
  • 19 Feb, 2024
  • 1 location
Featured trial
Test Study 2

Test Study 2

  • 0 views
  • 19 Feb, 2024
  • 2 locations
Featured trial
Acne study trial

Acne study trial

  • 6 views
  • 19 Feb, 2024
  • 2 locations
Featured trial
Build 10 Formal Testing

Build 10 Formal Testing

  • 0 views
  • 19 Feb, 2024
A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period

This is a prospective, interventional, single arm, multicenter, phase 4 study to evaluate the clinical efficacy and safety of initiating Insulin glargine U300 in insulin-naive patients or switching from any other basal insulin to Insulin glargine U300 in insulin pre-treated patients with uncontrolled T2DM.

  • 0 views
  • 19 Feb, 2024
  • 2 locations
Assessment of the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.

  • 0 views
  • 19 Feb, 2024